Novo Nordisk Lilly Shares Slump on Price-Cut Loom Plans
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Compare long-run outcomes for index versus active strategies, emphasizing time horizons, persistence of outperformance, and practical takeaways.
27,723 articlesNews of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Rocket Lab’s stock slides after another delay to the Neutron rocket, dimming the year’s record narrative. Investors p...
Three Amazon Web Services data centers in the Middle East were damaged by drone strikes, underscoring rapid regional ...
A federal court in SDNY dismissed all Anti-Terrorism Act claims against Binance and its former CEO, delivering a swee...
Oil and fuel costs are rising as tensions with Iran intensify. This report explains how energy markets are influencin...
As the Fed signals potential rate cuts, long-duration growth names with strong cash flows could re-rate. This piece f...
McDonald’s unveils its most aggressive value menu yet, with $3 items and a $4 breakfast bundle, signaling a shift in ...
Hess Midstream signals a major shift from expansion to cash returns, projecting $850-$900 million in adjusted free ca...
Target’s dividend king status remains intact for now, but a cash flow squeeze and higher capex raise questions for in...
NVIDIA still leads the AI chip race, but investors are spreading bets downstream to adjacent AI opportunities as the ...
A National Park Service interim report reveals debris from white house rubble dumped at East Potomac Golf Links tests...
With markets volatile in May 2026, delaying Social Security to age 70 can raise lifetime benefits. The breakeven poin...